Churbz: Give Lympro a chance to score it's first pharma clinical trial sale. That will fix a lot of things. That could happen in just a week or two. Once the market sees it's being embraced by pharma....the pps will go to where it ought to be. Yes, 2014 was hard for us, but it wasn't like AMBS didn't make incredible progress. The stock manipulators aren't giving AMBS credit for that progress yet, but once signs of revenue appear, the market will respond.

The scent of money always warms the market's heart.